Evidence map›Paper›PMID 42552372›Full record

Articlenpj health systems2026

Pre-trained knowledge transfer with application in multisystem inflammatory syndrome subphenotyping in children.

Xiaokang Liu, Naimin Jing, Yiwen Lu, Jason H Moore, Christopher B Forrest, James Zou, Yong Chen

Abstract read
In one paragraph

Article in npj health systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaokang LiuDepartment of Statistics and Data Science, University of Missouri, Columbia, MO, USA.
Naimin JingBiostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, USA.
Yiwen LuThe Center for Health AI and Synthesis of Evidence (CHASE), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jason H MooreCedars-Sinai Medical Center, Los Angeles, CA, USA.
Christopher B ForrestApplied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
James ZouDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Yong ChenThe Center for Health AI and Synthesis of Evidence (CHASE), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ychen123@upenn.edu.

Funding

OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
ReCARDO: Using Real-World Data to Derive Common Data Elements for Alzheimer's Disease and AD-Related Dementias Research Through Ontological InnovationU24AG098157 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Zoe Arvanitakis, Yong Chen · 2025 to 2026
$9.8M
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System DiseasesU01TR003709 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2022 to 2025
$4.7M
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting biasR01AG073435 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2025
$3.9M
Dynamic learning for post-vaccine event prediction using temporal information in VAERSR01AI130460 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHEN, YONG, TAO, CUI · 2017 to 2021
$3.4M
ClinEX - Clinical Evidence Extraction, Representation, and AppraisalR01LM014344 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yong Chen, Yifan Peng · 2023 to 2026
$2.7M
Novel evidence-accumulation-driven methods for characterizing kidney stone progressionR01DK128237 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI LIU, YU-LUN · 2022 to 2025
$2.7M
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methodsRF1AG077820 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2023 to 2023
$2.3M
PheBC: bias correction methods for EHR derived phenotypeR01LM013519 · NLM · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2024
$1.6M
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world DataR56AG069880 · NIA · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, CHEN, YONG · 2021 to 2022
$1.6M
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRDR56AG074604 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, TAO, CUI · 2021 to 2022
$1.5M
A General Framework to Account for Outcome Reporting Bias in Systematic ReviewsR01LM012607 · NLM · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG · 2017 to 2020
$1.4M
NCATS NIH HHS U01 TR003709NEI NIH HHS R21 EY034179NHLBI NIH HHS OT2 HL161847NIAID NIH HHS R01 AI130460NIAID NIH HHS R21 AI167418NIA NIH HHS R01 AG073435NIA NIH HHS R01 AG077820NIA NIH HHS R56 AG069880NIA NIH HHS R56 AG074604NIA NIH HHS RF1 AG077820NIA NIH HHS U24 AG098157NIDDK NIH HHS R01 DK128237NLM NIH HHS R01 LM012607NLM NIH HHS R01 LM013519NLM NIH HHS R01 LM014344
6 · The paper itself

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children and presents with highly heterogeneous signs and symptoms. Disentangling the clinical manifestations of MIS-C by characterizing its subphenotypes can help identify children at risk for severe outcomes and may help identify more targeted therapies. Characterizing subphenotypes usually requires large sample sizes and can often benefit from combining data from multiple sources. However, joint analysis often faces two major challenges: the prohibition of sharing patient-level data due to privacy concerns and between-study population clinical heterogeneity. To address both challenges, we propose a one-shot summary statistics-based framework to transfer knowledge of the shared subphenotypes pre-trained on large-scale source studies to a target study. Study-specific subphenotype mixing proportions are used to explain between-study heterogeneity. Both real-data guided simulation studies and an application to the MIS-C analysis demonstrate the benefits of our method.

Identifiers

PMID42552372
PMCPMC13439458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.